Tilray Brands (TLRY)
Sells cannabis, beverages, distribution and wellness products across regulated consumer markets.
Something off on this page? Send us feedback.
Sells cannabis, beverages, distribution and wellness products through a consumer-brands platform. Its structure combines legacy Tilray with Aphria's operating history and acquisition-built beverage brands.
Operating across cannabis, beverages, pharmaceutical distribution and wellness, the group sells medical and adult-use cannabis products alongside consumer brands. Its beverage platform began with Aphria's SweetWater acquisition and later added U.S. craft brands and BrewDog operations in the UK and Ireland.
The current company emerged from Aphria's reverse acquisition of legacy Tilray while retaining TLRY's Nasdaq listing. Operations combine cannabis production, beverage brands, distribution and hemp-based wellness products.
Cannabis activity depends on regulated medical and adult-use markets, and the operating mix reflects acquisitions across Canada, the United States and Europe.
Company facts
Target rangeAs of Sep 21, 2026
Latest analyst notes
| Date | Firm | Action | Prior | Current |
|---|---|---|---|---|
| Apr 2, 2026 | Roth Capital | Upgrade | ||
| Jan 20, 2026 | Roth Capital | Reiterate | Rating: —Target: $4 | Target: $10 |
| Jan 9, 2026 | Industrial Alliance Securities | Target | Target: $3 | Target: $10 |
| Dec 19, 2025 | Bernstein | Target | Target: — | Target: $10 |
EPSReportedEstimate
RevenueReportedEstimate
Balance sheet, May 31, 2026Cash & short-term investments $231.3M · Total debt $398.4M · Total assets $2.33B · Shareholders' equity $1.61B
- Revenue
- $281.7M
- Operating income
- −$4.5M
- Net income
- −$49.6M
No dividends on record.
| Institutions | 12.47% | 13.95M shares | |
|---|---|---|---|
| 254 holders · as of Jun 30, 2026 | |||
| Insiders | 5.49% | 6.14M shares | |
| 13 holders · as of Aug 27, 2026 | |||
| Other | 82.04% | 91.74M shares | |
| remainder | |||
111.83M company shares as of Sep 21, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
Two share counts disagree (136.20M in the company's Sep 22, 2026 report, 111.83M elsewhere); stakes use the report.
Top shareholders13F · 13D/G · Form 4
| Holder | Stake | Shares | Date |
|---|---|---|---|
Toroso Investments, LLCInstitution | 2.23% | 2.50M | as of Jun 30, 2026 |
Brendan Kennedy1Insiderdirector | 1.51% | 1.07M · 622,420 | filed Feb 16, 2021 |
Irwin D. SimonInsiderdirector, officer: President and CEO | 1.25% | 1.31M · 91,524 | filed Aug 27, 2026 |
Susquehanna International Group, LLPInstitution | 0.91% | 1.02M | as of Jun 30, 2026 |
Morgan StanleyInstitution | 0.89% | 995,145 | as of Jun 30, 2026 |
- Brendan Kennedy's transaction reports restate only vehicles that traded; the 2021 ownership statement (1.07M) is used instead.
Insider tradesForm 4
| Date | Insider | Role | Shares | Avg price |
|---|---|---|---|---|
| Aug 6, 2026 | Mitchell Gendel | officer: Global General Counsel | +2,500 | $4.43 |
| Aug 3, 2026 | Denise M. Faltischek | officer: Chief Strategy Officer | +2,500 | $4.78 |
| Aug 4, 2026 | Carl A. Merton | officer: Chief Financial Officer | +10,000 | $4.62 |
| Apr 21, 2026 | David G. Hopkinson | director | −33,556 | $6.94 |
- Canopy Growth
Canadian adult-use and medical cannabis with international reach
- Organigram Global
Canadian cannabis leader across flower, vapes, concentrates and edibles
- Cronos Group
Cannabis flower and extracts supplier in Canada and international markets
- Aurora Cannabis
Global medical cannabis provider with Canadian adult-use brands
Compare
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| Tilray Brands | $4.18 | +2.49% | $456.3M | — | — | 0.4 | +25.5% |
| Canopy Growth | $0.9263 | +0.27% | $390.0M | — | — | 1.7 | −20.8% |
| Organigram Global | $1.12 | −0.45% | $157.7M | 2.5 | 37.2 | 0.7 | +43.2% |
| Cronos Group | $3.37 | +1.05% | $1.24B | 18.4 | 56.1 | 5.1 | +58.4% |
| Aurora Cannabis | $4.04 | +0.17% | $249.6M | — | — | 1.2 | −34.0% |
| Median | 10.4 | 46.6 | 1.5 | +11.2% |